P2.11A.26 Prognostic Utility of Peripheral Myeloid Cells for Clinical Outcomes in Patients with NSCLC Treated with Cemiplimab
Autor: | Acosta, R.J., McIntyre, D.A.G., Murray, J.C., Anagnostou, V., Brahmer, J.R., Meisel, A., Sezer, A., Gogishvili, M., Melkadze, T., Baramidze, A., Makharadze, T., Seebach, F., Rietschel, P., Pouliot, J.-F., Kim, Y. |
---|---|
Zdroj: | Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS263-S264, 2p |
Databáze: | Supplemental Index |
Externí odkaz: |